United Therapeutics (UTHR) Tops Q3 EPS by $1.36, Revenues Beat
Tweet Send to a Friend
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.83, $1.36 better than the analyst estimate of $2.47. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
